Cosmetic injectables have become a go-to for smoother skin and fuller lips, but behind the growing demand lies a troubling reality: more people are falling victim to unsafe treatments and unqualified ...
Whether you’re looking to smooth out a stubborn wrinkle or add a little volume to your lips, the menu at a med spa can feel like a chemistry lab catalog. The substances used in treatments range from ...
Your favorite celebrities aren’t looking better because they’re getting less work done; they’re just getting better work. The last decade has been filled with loud, heavy cheekbones, over snatched ...
For more than a decade, injectable treatments have shaped the public conversation around aesthetic medicine. Quick appointments, minimal downtime, and subtle adjustments made neuromodulators and ...
BFS’s acquisition of Pleasant Valley Homes marks a strategic move into modular housing. M&A in the building materials industry is seeing fewer deals but larger transactions from top players. AI ...
When I was 25, it was easy to tell myself that I’d never have kids, stop eating bread, or get injectables. But then I got to my late 30s. “Look how unnatural that is!” he’d say. “You can’t move your ...
Our collective appetite for weight loss drugs has become pretty much insatiable over the past few years. It’s thought that around 1.5 million people in the UK are on GLP-1 agonist medications to curb ...
Enriched with bakuchiol, sea moss, hyaluronic acid and peptide complex, this is a deeply hydrating cream that can help restore elasticity for a more youthful appearance. Use it across your face, neck, ...
Incog BioPharma, a sterile injectables CDMO, plans to shell out around $200 million to boost production capacity at its Fishers, Indiana, manufacturing site. The company expects the project to add ...
Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 receptor agonist, helps people maintain weight loss after switching from an injectable, Eli Lilly ...
Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable therapies. The heavily back-loaded deal will see Moderna hand over just $3 ...
Lenacapavir and cabotegravir are among the most important advancements in HIV prevention and treatment within the past 10 years. Antonio Urbina, MD, the medical director for the Mount Sinai Institute ...